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        Introduction 
  FGF-23 is a recently discovered member of the FGF family of 
signaling proteins. It is a circulating factor derived from osteo-
cytes that acts to regulate kidney function and osteogenesis 
(  Yamashita, 2005  ;   Yu and White, 2005  ). FGF-23 is essential for 
maintaining phosphate homeostasis and has been linked to reg-
ulation of vitamin D (1,25(OH)  2 D 3  ) metabolism (  Yu and White, 
2005  ;   Liu et al., 2006  ;   Razzaque and Lanske, 2006  ). Although 
these phenomena have been well established, the signaling 
mechanisms of FGF-23 and potential target genes have yet to be 
investigated in detail. FGF-23 alone has minimal ability to pro-
mote intracellular signaling. Recent studies have shown that the 
function of FGF-23 is dependent on interaction with a hormone 
cofactor, Klotho (  Kurosu et al., 2006  ), which is a trans-membrane 
protein that binds FGF-23 (  Torres et al., 2007  ). Interaction of 
Klotho with the FGF receptor 1c (FGFR1c) converts it into a 
receptor specifi  c for FGF-23 function (  Urakawa et al., 2006  ). 
Upon formation of a ternary complex with FGF-23 and FGFR1c, 
phosphorylation of the receptor is achieved (  Kurosu et al., 
2006 ).  However,  little is known about the downstream effects 
caused by FGF-23  –  Klotho. In fact, the only signifi  cant molecular 
changes that have currently been observed from FGF-23 – Klotho 
function include phosphorylation of extracellular signal  –  regulated 
kinase (ERK), sodium phosphate transport regulation, and in-
creased Egr-1 (early growth responsive 1) gene expression (  Yu 
and White, 2005  ;   Kurosu et al., 2006  ). 
  The phenotypes observed from both   Fgf-23 
   /       and 
  Klotho 
   /       mice are consistent with premature aging. These in-
clude shortened life span, severe atrophy of most tissues/organs, 
soft tissue calcifi  cations, infertility, pulmonary emphysema, 
osteoporosis, and arteriosclerosis (  Kuro-o et al., 1997  ;   Razzaque 
et al., 2005  ,   2006  ;   Torres et al., 2007  ).   Fgf-23 
   /       and   Klotho 
   /      
mice also have increased serum phosphate levels. FGF-23  –
  Klotho has been found to inhibit phosphate transport in renal 
proximal tubule epithelial cells (PTEC) by direct regulation of 
the sodium phosphate cotransporters (  Yu and White, 2005  ). 
 Both   Fgf-23 
   /       and   Klotho 
   /       mice have unusually high 
serum levels of 1,25(OH)  2 D 3   (  Tsujikawa et al., 2003  ;   Shimada 
et al., 2004  ;   Sitara et al., 2004  ). Although vitamin D precursor 
molecules are steroid derived (  Johnson et al., 2002  ), an enzyme 
called 1    -hydroxylase (CYP27B1) is essential for the fi  nal 
synthesis of active vitamin D (  Dardenne et al., 2001  ). In fact, 
F
ibroblast growth factor 23 (FGF-23) and Klotho are 
secretory proteins that regulate mineral-ion metab-
olism.   Fgf-23 
    /        or   Klotho 
    /        knockout mice exhibit 
several pathophysiological processes consistent with pre-
mature aging including severe atrophy of tissues. We 
show that the signal transduction pathways initiated by 
FGF-23  –  Klotho prevent tissue atrophy by stimulating pro-
liferation and preventing apoptosis caused by excessive 
systemic vitamin D. Because serum levels of active vitamin D 
are greatly increased upon genetic ablation of   Fgf-23   
or   Klotho  , we ﬁ  nd that these molecules have a dual role 
in suppression of apoptotic actions of vitamin D through 
both negative regulation of 1    -hydroxylase expression 
and phosphoinositide-3 kinase  –  dependent inhibition of 
caspase activity. These data provide new insights into the 
physiological roles of FGF-23 and Klotho.
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a role in controlling FGF-23 function. We substituted Klotho 
with     -glucuronidase to assess potential effects on FGF-23  –
  induced signaling. Immunoblotting showed that    -glucuronidase 
had no effects on phosphorylation of ERK1/2 or AKT when 
combined with FGF-23 (unpublished data), confi  rming the unique 
role of Klotho in FGF-23 signaling. 
  FGF-23  –  Klotho signaling stimulates 
proliferation 
  Because the observed phosphorylation patterns are known to be 
associated with proliferation signaling pathways (  Bennasroune 
et al., 2004  ), we performed ELISA to detect potential effects of 
FGF-23 – Klotho on expression of the cell cycle proteins Cyclin D1 
and c-myc. Consistent with the phosphorylation patterning, we 
found that levels of Cyclin D1 and c-myc were signifi  cantly in-
creased with the addition of FGF-23 and Klotho to cell cultures 
compared with control cells. As expected, FGF-23 or Klotho alone 
had no signifi  cant effect on Cyclin D1 or c-myc expression. Ras 
inhibitor was suffi  cient to abolish most of the increased expression 
of these proteins under the infl  uence of FGF-23  –  Klotho, whereas 
PI3K inhibitor had only a minimal effect (  Fig. 2, A and B  ). 
  To observe potential alterations in cell proliferation medi-
ated by FGF-23  –  Klotho, we stained PTEC and FHs74Int cells 
in suspension for BrdU incorporation. No signifi  cant changes in 
proliferation were observed upon treatment of cells with FGF-23 
or Klotho alone compared with control cells. However, expo-
sure to both FGF-23 and Klotho greatly increased levels of BrdU 
incorporation. Introduction of Ras inhibitor to cultures nearly 
abolished increases in proliferation caused by FGF-23  –  Klotho, 
targeted inactivation of 1    -hydroxylase in mouse models 
(  1   -hydroxylase 
   /      ) results in undetectable serum levels of 
1,25(OH)  2 D 3   (  Dardenne et al., 2001  ). Therefore, it is reasonable 
to suggest that elevated serum levels of 1,25(OH)  2 D 3   in   Fgf-23 
   /      
or   Klotho 
   /       mice might be caused by the ability of these mole-
cules to regulate expression of the 1   -hydroxylase  gene.  The 
correlation between elevated levels of active vitamin D and the 
premature aging  –  like phenotype in   Fgf-23 
   /       and   Klotho 
   /      
mice makes it tempting to hypothesize that excessive active vita-
min D might have cytotoxic effects on various tissues, resulting 
in the observed atrophy. Studies in prostate and breast cancer 
cells have shown that exposure of cells to high levels of active 
vitamin D can have apoptotic effects (  Narvaez et al., 2001  ; 
 Johnson  et  al., 2002  ,   2006  ). Excessive activation of the vitamin D 
receptor causes transcription of genes associated with mito-
chondrial export of cytochrome   c   and subsequent cleavage of 
caspase-9. This action induces cleavage of caspase-3, which pro-
motes DNA fragmentation causing apoptosis (  Demay, 2006  ). 
  In this study, we show that FGF-23  –  Klotho stimulates mi-
togenic and cell survival pathways to prevent atrophy of tissues 
caused by excessive production of active vitamin D. High levels 
of 1,25(OH)  2 D 3   are suppressed by FGF-23  –  Klotho signaling 
through inhibited expression of renal 1    -hydroxylase, an enzyme 
responsible for synthesis of active vitamin D. Furthermore, we 
show that vitamin D  –  induced caspase activity is inhibited by 
signaling pathways initiated by FGF-23  –  Klotho, thus directly 
preventing apoptosis. 
  Results and discussion 
  FGF-23  –  Klotho signal transduction 
  To investigate the role of FGF-23 and Klotho in regulation of 
systemic vitamin D and tissue atrophy, we fi  rst performed protein 
analyses by immunoblotting. We found that exposure of renal 
PTEC or small intestine epithelial cells (FHs74Int) to exogenous 
FGF-23 or Klotho alone had minimal effects on protein phos-
phorylation of ERK1/2, p38, JNK, AKT, inhibitor   B (I  B), and 
GSK-3     (glycogen synthase kinase-3    ) compared with control 
(vehicle treated) cells. However, exposure to both FGF-23 and 
Klotho caused signifi  cant up-regulations in phosphorylation of 
all of these proteins (  Fig. 1  ). These data were confi  rmed by mul-
tiplex ELISA, which also showed increases in CREB (cAMP 
response element binding), p70S6K, and STAT3 (signal trans-
ducer and activator of transcription 3) phosphorylation by 
FGF-23  –  Klotho. Addition of a small molecule Ras inhibitor before 
FGF-23 and Klotho treatment prevented increased phosphoryl-
ation of CREB, ERK1/2, JNK, p38, p70S6K, and STAT3. Ad-
dition of a small molecule inhibitor against phosphoinositide-3 
kinase (PI3K) prevented increased phosphorylation of I   B, 
p70S6K, AKT, and GSK-3    . Combined effects of both Ras and 
PI3K inhibitors lowered all FGF-23  –  Klotho-induced phosphory  l-
ations to background levels (Fig. S1, A and B, available at http://
www.jcb.org/cgi/content/full/jcb.200803024/DC1). 
  No evidence of endogenous Klotho was observed in either 
PTEC or FHs74Int cells by immunoblotting (Fig. S1 C). Because 
Klotho has previously been described to act as a glucuronidase 
(  Tohyama et al., 2004  ), we sought to establish if this activity has 
  Figure 1.       Signaling events induced by FGF-23    –    Klotho.   Immunoblotting 
showing that FGF-23 or Klotho alone have no effect on kinase activity 
in PTEC or FHs74Int cells. Combined effects of FGF-23 and Klotho show 
increased phosphorylation of ERK1/2, p38, JNK, AKT, I    B, and GSK-3    . 
    -Tubulin was used as a loading control.     461 FUNCTIONAL ROLE OF FGF-23  –  KLOTHO   • Medici et al. 
rather to regulate mineral-ion homeostasis as previously described 
(  Yu and White, 2005  ). 
  FGF-23  –  Klotho signaling prevents 
vitamin D  –  induced apoptosis 
  Because active vitamin D has recently been described to have 
anti-cancer effects (  Johnson et al., 2002  ,   2006  ) and serum levels 
of 1,25(OH)  2 D 3   are excessively high in   Fgf-23 
   /       or   Klotho 
   /      
mice (  Tsujikawa et al., 2003  ;   Shimada et al., 2004  ;   Sitara et al., 
2004  ), we hypothesized that these elevated levels might pro-
mote apoptosis, thus causing the observed atrophy of tissues. 
We fi rst showed the direct effect of FGF-23  –  Klotho on expression 
of 1    -hydroxylase, the enzyme responsible for fi  nal synthesis 
of active vitamin D metabolite. Protein levels of 1   -hydroxylase 
were observed by ELISA, showing that FGF-23 and Klotho 
together were able to greatly reduce expression of this enzyme 
in PTEC cells compared with the control, whereas FGF-23 or 
Klotho alone had little effect. Addition of Ras and PI3K inhibi-
tors showed signifi  cant rescue of 1   -hydroxylase  expression, 
whereas PI3K inhibitor had only a minimal effect. Addition of 
both inhibitors completely prevented this increased prolifera-
tion (  Fig. 2 C  ). 
  Fgf-23 
   /       and FGF-23 transgenic mice were generated as 
previously described (  Larsson et al., 2004  ;   Sitara et al., 2004  ). 
Kidneys and intestines from these mice at 6 wk of age were sec-
tioned and stained for Ki67 expression to measure proliferation 
in vivo. Tissues from wild-type mice at 6 wk of age were used 
as a comparative control. In the intestine, we found that the 
number of Ki67-positive nuclei was signifi  cantly reduced in 
  Fgf-23 
   /       mice, whereas in FGF-23 transgenic mice it was 
greatly increased compared with the wild type (  Fig. 2, D and E  ). 
Similar results were observed in skin and spleen tissues (unpub-
lished data). Interestingly, in the kidney, there were dramatic 
changes in levels of cytoplasmic Ki67 but no positive staining 
for nuclear Ki67. We also attempted BrdU incorporation, but 
there was no positive staining in the nuclei from kidney sections 
(unpublished data). These data suggest that the role of FGF-23  –
  Klotho is not to control proliferation in the kidney in vivo but 
  Figure 2.       FGF-23    –    Klotho signaling promotes 
cell proliferation.   (A and B) ELISA analysis 
showing increased expression of the cell cycle 
proteins Cyclin D1 (A) and c-myc (B) upon ex-
posure of cells to FGF-23 and Klotho. FGF-23 
or Klotho alone had little effect on expression 
of these proteins. Addition of a small molecule 
Ras inhibitor nearly abolished up-regulation 
of these proteins by FGF-23  –  Klotho, whereas 
PI3K inhibitor had minimal effect. Graphs 
represent mean   ±   SD (  n   = 3). *, P   <   0.001. 
(C) Flow cytometry analysis for BrdU incorpor-
ation under these conditions showing that cell 
proliferation correlated with the observed ex-
pression patterns for Cyclin D1 and c-myc. 
(D and E) Ki67 immunostaining showing that 
expression was lower in   Fgf-23 
    /        mice and 
higher in FGF-23 transgenic mice. Intestinal 
tissue showed intense nuclear Ki67 staining 
(E), whereas the kidney tissue only stained in 
the cytoplasm. Bar, 100   μ  m. Graphs represent 
mean   ±   SD (  n   = 3). *, P   <   0.05.     JCB • VOLUME 182 • NUMBER 3 • 2008  462 
vitamin D, FGF-23 or Klotho alone showed no differences in 
levels of apoptosis. However, upon addition of both FGF-23 and 
Klotho, there was a substantial rescue of vitamin D  –  induced 
apoptosis. Ras inhibitor had no effect on this rescue, but PI3K 
inhibitor prevented the FGF-23 – Klotho-induced rescue of apop-
tosis caused by excessive active vitamin D (  Fig. 3 B  ). We per-
formed ELISA for detection of levels of activated (or cleaved) 
caspase-3 (  Fig. 3 C  ) with expression patterns nearly identical to 
those observed by TUNEL staining. 
  To directly observe whether kidneys of   Fgf-23 
   /       mice 
express higher levels of 1    -hydroxylase, thus resulting in the 
previously described high levels of serum vitamin D, we per-
formed real-time quantitative PCR using RNA isolated from 
these tissues compared with those of wild-type mice. As ex-
pected, we found levels of 1    -hydroxylase to be far higher in 
kidney tissue of knockout mice compared with that of wild-type 
mice. We also found that there was no signifi  cant change in 1   -
hydroxylase mRNA in intestinal tissue (  Fig. 4 A  ). Histology of 
kidney and intestinal tissues from   Fgf-23 
   /       mice show high 
levels of apoptosis compared with those of wild-type mice, as 
however full restoration was not achieved. These data suggest 
that other signaling pathways may also be involved in regula-
tion of 1    -hydroxylase expression. Interestingly, no statistically 
signifi  cant changes in expression of 1   -hydroxylase were found 
with treatment of FHs74Int cells (  Fig. 3 A  ). This is consistent 
with the fact that PTEC of the kidney are the primary site of 1   -
hydroxylase activity for synthesis of active vitamin D ( Dardenne 
et al., 2001  ) not small intestinal epithelium. 
  To assess effects of 1,25(OH)  2 D 3   on PTEC or FHs74Int 
cells, we established a dose-dependent curve of active vitamin D 
treatment with steadily increasing amounts added to cultures. 
Cells were stained in suspension for apoptosis by TUNEL and 
subjected to fl  ow cytometry. We found that a dose of 100 nM of 
vitamin D had little effect on levels of apoptosis compared with 
vehicle-treated control cells. Although a 200-nM concentration 
showed signifi  cant but relatively low cell death, a 300-nM dose 
heavily increased levels of apoptosis. 400 nM of vitamin D 
caused cell death of nearly the entire populations of PTEC and 
FHs74Int cells (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200803024/DC1). In the presence of 400 nM of 
  Figure 3.       FGF-23    –    Klotho prevents vitamin D  – 
induced apoptosis.   (A) ELISA analysis of 
1    -hydroxylase expression showing no signiﬁ  -
cant changes in PTEC cells exposed to FGF-23 
or Klotho alone but greatly decreased levels 
when exposed to both FGF-23 and Klotho. 
Small molecule inhibitors against Ras and PI3K 
were sufﬁ  cient to provide marginal rescue of 
this decrease in expression. No signiﬁ  cant 
changes were found for treatment of FHs74Int 
cells. Graphs represent mean   ±   SD (  n   = 3). 
*, P   <   0.05. (B) Flow cytometry analysis for 
TUNEL staining of cells exposed to exogenous 
vitamin D showing that it caused extremely 
high levels of apoptosis. Addition of FGF-23 
and Klotho was sufﬁ  cient to rescue most of the 
vitamin D  –  induced apoptosis, whereas FGF-
23 or Klotho alone did not. PI3K inhibitor pre-
vented this rescue, whereas Ras inhibitor had 
no effect. (C) ELISA for active caspase-3 levels, 
showing the same patterns as observed with 
the TUNEL analysis. Graphs represent mean   ±   
SD (  n   = 3). *, P   <   0.001.     463 FUNCTIONAL ROLE OF FGF-23  –  KLOTHO   • Medici et al. 
(intestine, spleen, and skin) showed effects of FGF-23  –  Klotho 
on proliferation. Although kidneys of   Fgf-23 
   /       mice showed no 
evident change in proliferation, in vitro studies of kidney PTEC 
demonstrated greatly increased proliferation as a result of expo-
sure to exogenous FGF-23 and Klotho. These data suggest that 
there are distinct regulatory factors controlling in vivo prolifera-
tion for each organ that may render FGF-23  –  Klotho ineffective 
for this purpose. However, it is clear that FGF-23  –  Klotho does 
inhibit expression of 1    -hydroxylase in kidney cells (in vitro 
and in vivo) and subsequent production of active vitamin D. 
Although the concentrations of active vitamin D used for our in 
vitro studies may not be the same as those reached in vivo in 
  Fgf-23 
   /       mice, evidence of apoptotic rescue by genetic knock-
out of   1   -hydroxylase   suggests that active vitamin D is the 
cause of the observed tissue atrophy. 
  The potential use of FGF-23  –  Klotho as an antiaging ther-
apy is tempting; however, there is great risk. Although exces-
sive serum levels of active vitamin D are clearly responsible for 
several aging-like phenotypes, including tissue atrophy, moder-
ate production of active vitamin D is still essential for normal 
bone mineralization (  Christakos et al., 2006  ). Also, lack of sys-
temic vitamin D has been linked to increased risk in develop-
ment of various forms of cancer including colorectal, breast, 
lung, ovarian and prostate carcinomas, as well as non-Hodgkin  ’  s 
observed by TUNEL staining. Most signifi  cantly, tissues from 
  Fgf-23 
   /   /1  -hydroxylase 
   /       mice show a complete rescue of 
the apoptosis seen in   Fgf-23 
   /       mice (  Fig. 4, B and C  ). Similar 
results were found in other organs including skin, spleen, liver, 
lung, ovaries, and testes (unpublished data). These data suggest 
that systemically elevated active vitamin D is the cause of tissue 
atrophy observed in   Fgf-23 
   /       mice. 
 This study provides a foundation for understanding the sig-
nal transduction mechanisms initiated by FGF-23 and Klotho, 
processes that until now were relatively unknown. We have also 
provided insight into the physiological functions of these pro-
teins, which regulate cell survival, proliferation, and vitamin D 
metabolism. These discoveries go beyond the traditional dogma 
of FGF-23 and Klotho being responsible for maintaining 
mineral-ion homeostasis (  Yu and White, 2005  ). It is now clear 
that two major signal transduction pathways are initiated by 
FGF-23  –  Klotho. Ras signaling promotes downstream kinase activ-
ities that cause up-regulation of cell cycle genes to induce prolifera-
tion, whereas PI3K signaling counter regulates apoptotic pathways 
through its downstream activation of AKT (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200803024/DC1). 
  Perhaps the most interesting aspect of our study is that al-
though virtually all internal organs showed evidence of vitamin 
D – induced  apoptosis  in   Fgf-23 
   /       mice, only select tissues 
  Figure 4.       Genetic ablation of 1    -hydroxylase prevents 
apoptosis and atrophy in tissues of   Fgf-23 
    /        mice.  
(A) Real-time quantitative PCR analysis showing that gene 
expression levels of 1    -hydroxylase from kidney tissues 
of   Fgf-23 
    /        mice is much higher than those of wild-type 
(control) mice. Graphs represent mean   ±   SD (kidney,   n   = 6; 
intestine,   n   = 5 ). *, P   <   0.01. (B and C) TUNEL staining 
of tissue sections from kidney and intestine of   Fgf-23 
    /        
mice showing far higher levels of apoptosis than those 
of wild-type mice.   Fgf-23 
    /     /1    -hydroxylase 
    /        double 
knockout mice show a complete rescue of the apoptosis 
seen in tissues of   Fgf-23 
    /        mice. Bar, 100   μ  m. Graphs 
represent mean   ±   SD (  n   = 3). *, P   <   0.001.     JCB • VOLUME 182 • NUMBER 3 • 2008  464 
and In Situ Cell Death Detection kit, Fluorescein (Roche), respectively, using 
the protocols provided by the manufacturer (Roche). Flow cytometry was 
performed at the Harvard Medical School Department of Pathology ﬂ  ow 
cytometry core facility using a FACSDCalibur (BD Biosciences) cell sorter 
isolating 30,000 cells per sample. 
  Real-time quantitative PCR 
  Quantitative RT-PCR was performed to quantify the relative expression 
of 1    -hydroxylase mRNA in the kidney and intestine of 6-wk-old wild-
type or   Fgf-23 
    /        mice. Tissues were snap frozen in liquid nitrogen and 
total RNA was isolated by phenol chloroform extraction using Trizol Re-
agent. Subsequently, 1   μ  g of RNA was reverse transcribed using the 
QuantiTectR Reverse Transcription kit (Qiagen). RT-PCR was performed 
using a real-time PCR system (ABI 7300; Applied Biosystems) with the 
following conditions: initial denaturing at 95  °  C for 2 min, followed by 
45 three-step cycles of denaturing at 95  °  C for 10 s, annealing at 55  °  C 
for 20 s, and extension at 68  °  C for 1 min. The following primers were 
used: 1a-hydroxylase forward, 5    -CAGATGTTTGCCTTTGCCC-3     and 
reverse, 5    -TGGTTCCTCATCGCAGCTTC-3    ; and m36B4 forward, 5    -
AGATGCAGCAGATCCGCAT-3     and reverse, 5    -GTTCTTGCCCATC-
AGCACC-3    . All samples were run in triplicate using SYBR green 
(Eppendorf) and compared with levels of endogenous m36B4 as an in-
ternal control. 
  Mice 
    Fgf-23 
    /       ,   1    -hydroxylase 
    /       , and FGF-23 transgenic mice were generated 
as previously described (  Dardenne et al., 2001  ;   Larsson et al., 2004  ;   Sitara 
et al., 2004  ).   Fgf-23 
    /     /1    -hydroxylase 
    /        mice were created by cross-
breeding   FGF-23 
    /        with   1    -hydroxylase 
    /        mice (  Razzaque et al., 2006  ). 
Standard PCR genotyping was performed using the following primers: 
Fgf-23, forward, 5    -GGATCCCCACCTCAGTTCTCA-3     and reverse, 5    -TAG-
CCGTGTACAGGTGGGTCA-3    ;   1    -hydroxylase   forward,  5    -GCACCTG-
GCTCAGGTAGCTCTTC-3     and reverse, 5    -GTCCCAGACAGAGACATC-
CGT-3    ; and FGF-23 Transgenic forward, 5    -GGCAACATTTTTGGATCA-3     
and reverse, 5    - CCGGGGCTTCAGCACGTT-3    . 
  Immunohistochemistry 
  Immunohistochemistry was performed using Ki67 antibody (Dako) accord-
ing to the manufacturer  ’  s guidelines with a 1:100 dilution. Nova Red (Vec-
tor Laboratories) POD substrate was used for Ki67 staining. TUNEL staining 
was conducted using the In Situ Cell Death Detection kit, Fluorescein and 
protocol. All sections (provided by T. Taguchi, Nagasaki University, Naga-
saki, Japan) for Ki67 were counterstained with hematoxylin, whereas sec-
tions for TUNEL were counterstained with DAPI in ﬂ  uorescent  mounting 
medium (Vector Laboratories). Data were quantiﬁ  ed by counting the num-
ber of Ki67- or TUNEL-positive nuclei per mm 
2  . Images were acquired us-
ing a ﬂ   uorescence microscope (80i; Nikon) at 25  °  C with 10 or 20  ×   
magniﬁ  cations. Fluorescein ﬁ  lters were used to detect TUNEL. Images were 
captured using a charge-coupled device camera (Orca 100; Hamamatsu 
Photonics) and MetaMorph software (MDS Analytical Technologies). Ad-
justments of total image size, brightness, and contrast were made using 
Photoshop CS. 
  Statistics 
  One-way analysis of variance was performed and conﬁ   rmed with two-
tailed paired Student  ’  s   t   test using Prism 4 software (GraphPad Software, 
Inc.). P-values   <  0.05 were considered signiﬁ  cant. 
  Online supplemental material 
  Fig. S1 shows phosphorylation targets of FGF-23  –  Klotho signaling by 
ELISA and control immunoblotting for Klotho expression. Fig. S2 shows 
dose-dependent effects of active vitamin D on apoptosis (TUNEL) of PTEC 
or FHs74Int cells by ﬂ  ow cytometry. Fig. S3 is a schematic diagram of 
FGF-23  –  Klotho signal transduction. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200803024/DC1. 
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lymphoma. Furthermore, there is strong evidence that vi-
tamin D defi  ciency increases the risk of developing other 
pathological conditions such as multiple sclerosis, type 1 and 
type 2 diabetes mellitus, rheumatoid arthritis, osteoarthritis, hy-
pertension, and stroke (  Grant, 2006  ;   Peterlik and Cross, 2006  ). 
Pharmacological doses of vitamin D analogues have been used 
as potential therapies against these conditions (  Hayes, 2000  ; 
  Holick, 2006  ;   Deeb et al., 2007  ). The ability of FGF-23  –  Klotho 
signaling to inhibit synthesis of active vitamin D through inhibitory 
control of 1    -hydroxylase gene expression, as well as to induce 
signaling pathways that counter-regulate vitamin D  –  induced 
apoptotic signaling, could potentially slow the aging process. 
However, it would also likely increase the risk of developing 
diseases associated with vitamin D defi  ciency. Therefore, it is evi-
dent that a balance of moderate levels of systemic active vita-
min D is essential for maintaining overall health and longevity. 
  Materials and methods 
  Cell culture 
  Human renal PTEC were obtained from Clontech Laboratories, Inc. FH-
s74Int human small intestine epithelial cells were acquired from the Ameri-
can Type Culture Collection. PTEC cells were grown in culture using REBM 
(Clontech Laboratories, Inc.) + 10% FBS + 1% penicillin/streptomycin. 
FHs74Int were grown in HybriCare medium (American Type Culture Collec-
tion) + 10% FBS + 1% penicillin/streptomycin. FBS was removed 24 h 
before all experimental conditions. Recombinant FGF-23 and Klotho pro-
teins (generated as previously described [  Kurosu et al., 2006  ;   Yu et al., 
2005  ]) were added to the culture medium for all relative experiments at 
concentrations of 10 ng/ml and 200 pM, respectively. Cells were treated 
for 15 min to assess kinase activity or for 12 h to measure proliferation. Vi-
tamin D (Sigma-Aldrich) was used at a cytotoxic concentration of 400 nM 
for 24 h. Small molecule Ras (FTI-276; provided by M. Azam, Harvard 
Medical School, Boston, MA) and PI3K (LY294002; Cell Signaling Tech-
nology) inhibitors were added 1 h before experiments at a concentration 
of 1   μ  M.     -glucuronidase (Sigma-Aldrich) was used at a concentration of 
200 ng/ml. 500 ng of the pcDNA3.1/V5-His-TOPO-Klotho (provided by 
D.E. Arking, Johns Hopkins University, Baltimore, MD) plasmid was trans-
fected into cells using Lipofectamine and Plus reagents (Invitrogen) accord-
ing to the manufacturer  ’  s guidelines. All experiments for this study were 
performed in triplicate. 
  Immunoblotting 
  Western blotting was performed using the following antibodies at concen-
trations (and using protocols) recommended by the respective manufac-
turers: P-ERK1/2, ERK1/2, P-p38, p38, P-JNK, JNK, P-AKT, AKT, P-GSK-3    , 
GSK-3    , and I    B (Cell Signaling Technology); P-I    B (Santa Cruz Biotech-
nology, Inc.); Klotho (provided by M. Kuro-o); and     -tubulin (EMD). HRP-
conjugated secondary antibodies (EMD) were used at a dilution of 
1:5,000. Adjustments of total image size, brightness, and contrast were 
made using Photoshop CS (Adobe). 
  Multiplex ELISA 
  Signal transduction was assessed using the Beadlyte 8-plex Multi-Pathway 
Signaling kit (Millipore). Active caspase-3 beadmates (Upstate Biotech-
nology) were used to assess apoptosis. P-AKT, P-GSK-3     (Cell Signaling 
Technology), Cyclin D1, c-myc, and CYP27B1 (Santa Cruz Biotechnol-
ogy, Inc.) antibodies were conjugated to various Bio-Plex carboxylated 
beads (with unique optical codes) using the Bio-Plex Amine Coupling kit 
(Bio-Rad Laboratories).     -Tubulin antibody (EMD) was also conjugated to 
Bio-Plex carboxylated beads to be used as an internal control. Samples 
were run on a Luminex 200 multiplex testing system using the Universal 
Cell Signaling Assay kit and corresponding protocol (Millipore). Experi-
mental values were divided by the     -tubulin control values to provide nor-
malized data. 
  Flow cytometry 
  PTEC and FHs74Int cells were stained in suspension for BrdU or TUNEL 
incorporation with the 5-Bromo-2    -deoxy-uridine Labeling and Detection kit I 465 FUNCTIONAL ROLE OF FGF-23  –  KLOTHO   • Medici et al. 
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